CONTINUING PHARMACY EDUCATION

Drug Topics and The University of Connecticut School of Pharmacy launch the next generation of learning for pharmacists

Beginning with the September issue, learn about Opioid Pain Management: Balancing Risks and Benefits. You'll earn 2 free CPE credits and enhance your skills with this valuable online benefit

Click here for more information and to access the program.

HEALTHCARE TEAMS

Physician-pharmacist collaboration helps patients improve cholesterol levels

Investigators’ 2-year trial demonstrates that remotely located physician-pharmacist team-based care resulted in significantly improved low-density lipoprotein cholesterol levels and goal attainment among patients with diabetes. » More

FDA ACTIONS

FDA approves first biologic treatment for children with ulcerative colitis

FDA approves infliximab (Remicade, Janssen Biotech) for the treatment of moderately to severely active ulcerative colitis in pediatric patients older than 6 years who have shown an inadequate response to conventional therapy. » More

CLINICAL NEWS

Outpatient treatment of pulmonary embolism safe for low-risk patients

Most pulmonary embolism patients who are hemodynamically stable still receive hospital-based treatment, despite practice guidelines stating the contrary. A recent international study suggests that outpatient care is a safe, effective alternative for select low-risk patients. » More

Anti-nausea drug ondansetron may lead to fatal arrhythmias: FDA

FDA examines the possibility that ondansetron (Zofran, GlaxoSmithKline) may lead to abnormal and potentially fatal heart arrhythmias. » More

Expanded vaccine recommendations appear to reduce ER flu visits

The U.S. Advisory Committee on Immunization Practices’ recommendation that healthy children 2 to 4 years of age be vaccinated for seasonal influenza appears to have had a direct and indirect effect on reduction of illness in 2 specific groups. » More

Current methods to assess medication adherence may result in inflation

Medication adherence estimates were inflated by 9% to 18% when early nonadherent patients were omitted from adherence calculations, reported a study of 15,417 patients. » More

Voices

Digital Edition